Oligo-fucoidan was found to have anti-HCC [32] and hepato-protection effects [42], as well as an anti-angiogenesis function [43], and thus it may have a synergistic effect of enhancing anti-HCC efficacy by combining with WNK1/OSR1 inhibitors. Here, WNK1 is linked to hepatocellular carcinoma.